Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Breast Cancer Research : BCR|November 11, 2023
AMEERA-4: a randomized, preoperative window-of-opportunity study of amcenestrant versus letrozole in early breast cancerMario Campone, François-Clément Bidard, Patrick Neven, et al.Behavioural Brain Research|April 7, 2015
Distribution of serotonin 5-HT1A-binding sites in the brainstem and the hypothalamus, and their roles in 5-HT-induced sleep and ingestive behaviors in rock pigeons (Columba livia)Tiago Souza Dos Santos, Jéssica Krüger, Fernando Falkenburger Melleu, et al.Psychiatry Research|June 6, 2018
Neurological soft signs as a marker of cognitive impairment severity in people living with HIVPablo Toro, María Elena Ceballos, José Pesenti, et al.Mycoses|May 27, 2015
Relevance of Candida and other mycoses for morbidity and mortality in severe sepsis and septic shock due to peritonitisChristoph Lichtenstern, Christina Herold, Markus Mieth, et al.Plos One|May 23, 2012
Reduced gray to white matter tissue intensity contrast in schizophreniaLi Kong, Christina Herold, Bram Stieltjes, et al.JAMA Oncology|October 11, 2019
Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A Phase 2 Clinical TrialJoyce F Liu, Christina Herold, Kathryn P Gray, et al.Cancer|September 5, 2014
Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panelNadine Tung, Chiara Battelli, Brian Allen, et al.Journal for Immunotherapy of Cancer|February 26, 2025
Phase I study of ribociclib (CDK4/6 inhibitor) with spartalizumab (PD-1 inhibitor) with and without fulvestrant in metastatic hormone receptor-positive breast cancer or advanced ovarian cancerAna C Garrido-Castro, Noah Graham, Lestat R Ali, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2016
Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain MetastasesRachel A Freedman, Rebecca S Gelman, Jeffrey S Wefel, et al.Journal of the National Cancer Institute|July 12, 2023
Adjuvant endocrine therapy uptake, toxicity, quality of life, and prediction of early discontinuationFélix Balazard, Aurélie Bertaut, Élise Bordet, et al.Pageof 4